Evidence on ketogenic diets remains limited for psychiatric disorders and diabetes, while a systematic review in overweight and obese women with PCOS found significant short-term improvements. Experts said more controlled, long-term studies are needed.
HCW Biologics and WY Biotech closed first-round financing for joint venture Trimmune, granting exclusive worldwide license to develop preclinical TRBC molecule HCW11-006 for $7 million in upfront consideration, with Phase 1 trial planned in China for first half of 2027.
International researchers have identified a specific antibody mutation that causes rare but serious blood clots after adenovirus-based COVID-19 vaccines or natural adenovirus infection, providing a roadmap for safer vaccine design.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT06342700 |
A Food Effect and Relative Bioavailability Study of Rilzabrutinib in Healthy Participants |
COMPLETED | PHASE1 |
| NCT05704153 |
Modelling and Control of Non-invasive Vagus Nerve Stimulation for Autoimmune Diseases (1A) |
RECRUITING | NA |
| NCT05447143 |
Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis |
COMPLETED | NA |
| NCT04452305 |
Spermatogonial Stem Cell (SSC) Transplant and Testicular Tissue Grafting |
RECRUITING | NA |
| NCT04186871 |
Study to Assess Safety and Effectiveness of Branebrutinib Treatment in Participants With Active Systemic Lupus Erythematosus or Primary Sjögren's Syndrome, or Branebrutinib Treatment Followed by Open-label Abatacept Treatment in Study Participants With Active Rheumatoid Arthritis |
COMPLETED | PHASE2 |
